MRI contrast agent turns on at sites of disease

14th February 2017
Posted By : Enaie Azambuja
MRI contrast agent turns on at sites of disease


At the Institute for Basic Science (IBS) in South Korea, researchers have developed a type of MRI contrast agent that only lights up when near a target. It consists of two components, an “enhancer” which is the actual contrast agent that lights up and a “quencher” that controls the activation of the enhancer.

The enhancer remains in an “on” state as long as the quencher is at a distance, but as soon as the two are brought within 7 nanometers of each other, the contrast agent turns off and becomes invisible under MRI. Actually using these two components to visualise a target involves delivering them together, linked so that they’re near each other and so keeping the enhancer in an “off” state.

The molecular link keeping them together needs to be designed so that an enzyme that is produced by a target tumor will cut the link. Once the enhancer and quencher are disconnected, they soon move apart and find themselves at least 7 nanometers from each other, allowing the enhancer to activate and show up bright and loud on the MRI.

Of course the same method can be used to visualise not only cancer, but many other biological processes. It’s simply a matter of creating different links between the enhancer and quencher that break when in the environment of a given biological target.

You must be logged in to comment

Write a comment

No comments

More from Institute for Basic Science

Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

Building IoT products for smart healthcare market
8th February 2018
United Kingdom Cocoon Networks, London
Medical Japan 2018
21st February 2018
Japan INTEX Osaka
Med-Tech Innovation Expo 2018
25th April 2018
United Kingdom Ricoh Arena, Coventry